诊断性乳腺影像中BI-RADS 5类评估:基于病灶描述词的结局分析
研究回顾2010年1月至2015年9月共22564次连续诊断性乳腺影像检查,其中239次(1.1%)评估为BI-RADS 5类,以病理为金标准,PPV3为97.5%(95%CI 96.2%-98.8%)。在同时行乳腺X线和超声的220次检查中,98.6%(217/220)的5类病灶有≥4个可疑BI-RADS描述词,仅3个病灶有3个可疑描述词,无病灶少于3个。
要点
- BI-RADS 5类评估的PPV3为97.5%(95%CI 96.2%-98.8%),达到≥95%的预期目标。
- 同时行乳腺X线和超声时,98.6%(217/220)的5类病灶有≥4个可疑描述词。
- 仅3个病灶有3个可疑描述词,无5类病灶少于3个可疑描述词。
核心结论
- 临床实践中可做出PPV≥95%的BI-RADS 5类评估;要支持5类评估,应在诊断性乳腺X线与超声联合检查中识别至少4个可疑BI-RADS描述词。
研究设计与样本
- 符合《健康保险携带和责任法案》、经IRB豁免的回顾性研究,纳入2010年1月至2015年9月共22564次连续诊断性乳腺影像检查(乳腺X线和/或超声),其中239次(1.1%)评估为BI-RADS 5类,平均年龄62.5岁,以病理诊断为金标准计算PPV3。
关键影像表现/征象
- 239次5类评估中恶性肿瘤(浸润性乳腺癌和/或导管原位癌)诊断于233次检查,PPV3为97.5%(95%CI 96.2%-98.8%)。
- 最常见的病灶类型为肿块(170个)和钙化(116个)。
- 在同时行乳腺X线和超声的220次检查中,无5类病灶少于3个可疑BI-RADS描述词。
诊断标准与关键数值
- BI-RADS图谱定义5类评估仅适用于几乎肯定是癌的病灶,阳性预测值(PPV)≥95%。
- 同时行诊断性乳腺X线和超声时,5类病灶中98.6%(217/220)有≥4个可疑BI-RADS描述词。
- 同时行诊断性乳腺X线和超声时,仅3个5类病灶有3个可疑BI-RADS描述词,无病灶少于3个可疑描述词。
临床应用与阅片要点
- 要支持BI-RADS 5类评估,应在诊断性乳腺X线与超声联合检查中识别至少4个可疑BI-RADS描述词。
- 本研究中5类评估的PPV3为97.5%(95%CI 96.2%-98.8%),符合BI-RADS 5类≥95% PPV的定义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The Breast Imaging-Reporting and Data System (BI-RADS) atlas defines category 5 assessments as appropriate only for lesions that are almost certainly cancer, with a positive predictive value (PPV) of ≥95%. This study aims to demonstrate the feasibility of classifying lesions at diagnostic breast imaging with sufficiently high PPV to merit category 5 assessments, and to identify those lesion descriptors that yield such a high PPV.
MATERIALS AND METHODS: For this Health Insurance Portability and Accountability Act compliant and IRB exempt study, we reviewed diagnostic breast imaging examinations (mammography and/or ultrasound) assessed as highly suggestive of malignancy (BI-RADS category 5). Pathology diagnosis was considered the gold standard. PPV3 (biopsy performed) was calculated, and the BI-RADS descriptors for each lesion were analyzed.
RESULTS: Among 22,564 consecutive diagnostic breast imaging examinations between January 2010 and September 2015, we identified 239 exams (1.1%) assessed as BI-RADS category 5 (mean age 62.5 years). Malignancy (invasive breast carcinoma and/or ductal carcinoma in situ) was diagnosed in 233 examinations (PPV3 97.5% and 95% confidence interval: 96.2%-98.8%). The most common lesion types were mass (170) and calcifications (116). Of the 220 examinations involving both mammography and ultrasound, no category 5 lesions had <3 suspicious BI-RADS descriptors, only three lesions had three suspicious descriptors, but the remaining 217 lesions (98.6%) had ≥4 suspicious descriptors.
CONCLUSION: In clinical practice, it is feasible to make BI-RADS category 5 assessments with the intended ≥95% PPV. To justify a category 5 assessment, at least four suspicious BI-RADS descriptors should be identified at the combination of diagnostic mammography and ultrasound examinations.
引用
- Yao MM, Joe BN, Sickles EA, et al. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors. Acad Radiol. 2018. PMID: 30195413. doi:10.1016/j.acra.2018.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。